Target HypoxiaClass NitroimidazoleOther names FMISO
Structure from the cited PubChem record (unlabelled ligand, or the labelled form when PubChem only describes that one). Conformer: PubChem (3D conformer computed by PubChem). Rotate with the mouse or a finger.
| Form | Use | Molar mass (labelled form) | Ongoing trials | Most advanced phase | Approval |
|---|---|---|---|---|---|
| [¹⁸F]FMISO Syntheses and QC ↗ | Imaging | 188.15 | 12 | Phase 2 | — |
Atlas trials whose studied drug or title names this vector, with this radionuclide.
| Trial | Phase | Status | Sponsor | Countries |
|---|---|---|---|---|
| Hypoxia tracers (FMISO, FAZA, ATSM)NCT03649880 · Brain (glioma, medulloblastoma…) | Phase 2 | Recruiting | OHSU Knight Cancer Institute | 1 |
| Hypoxia tracers (FMISO, FAZA, ATSM)NCT03168737 · Breast | Phase 1 | Active, not recruiting | M.D. Anderson Cancer Center | 1 |
| Hypoxia tracers (FMISO, FAZA, ATSM)NCT04332588 · Breast | Phase 1 | Recruiting | University of Alabama at Birmingham | 1 |
| Hypoxia tracers (FMISO, FAZA, ATSM)NCT04861077 · Breast | Phase 1 | Recruiting | University of Alabama at Birmingham | 1 |
| Hypoxia tracers (FMISO, FAZA, ATSM)NCT05047913 · Brain (glioma, medulloblastoma…) | Phase 1 | Active, not recruiting | M.D. Anderson Cancer Center | 1 |
| Hypoxia tracers (FMISO, FAZA, ATSM)NCT07778979 · Brain (glioma, medulloblastoma…) | Phase 1 | Not yet recruiting | University of Alabama at Birmingham | 1 |
| Hypoxia tracers (FMISO, FAZA, ATSM)NCT05996432 · Head and neck | Phase 1 | Recruiting | Vanderbilt-Ingram Cancer Center | 1 |
| Hypoxia tracers (FMISO, FAZA, ATSM)NCT03418818 · Sarcoma / bone | No phase | Active, not recruiting | University Health Network, Toronto | 1 |
| FAZA Lung · Hypoxia tracers (FMISO, FAZA, ATSM)NCT02701699 · Non-small-cell lung cancer | No phase | Active, not recruiting | University Health Network, Toronto | 1 |
| Hypoxia tracers (FMISO, FAZA, ATSM)NCT04054609 · Ischemic heart disease | No phase | Recruiting | University Health Network, Toronto | 1 |
| Hypoxia tracers (FMISO, FAZA, ATSM)NCT01549730 · Gynecological | No phase | Active, not recruiting | University Health Network, Toronto | 1 |
| Hypoxia tracers (FMISO, FAZA, ATSM)NCT04395469 · Pancreas (adenocarcinoma) | No phase | Active, not recruiting | University Health Network, Toronto | 1 |
686 publications in PubMed for the query below; the most recent:
FMISO[tiab] OR fluoromisonidazole[tiab]
Sources: PubChem and PubMed (NCBI), ClinicalTrials.gov and CTIS registries, approvals recorded by the atlas. PubChem data as of 28 October 2026.
Fluoromisonidazole. Theranostic Atlas, LaRadiopharmacie.fr. Data as of 27 October 2026. https://theranosticatlas.com/molecule/fmiso/ (accessed [date]).
A monitoring tool with no regulatory value: check every item at its source.